Single-Use Technologies for Biopharmaceuticals Market

Single-use Technology for Biopharmaceuticals Market – Overview

The increasing awareness about various therapeutic application of biotherapy stands as a key factor augmenting the growth of the global single-use technology for biopharmaceuticals market. Single-use technology is disposable product that is meant to be used one-time. They are made of various types of plastic such as cellulose acetate, polycarbonate, polyethylene, ethylene vinyl acetate, and polyamide. The rising adoption of single-use disposables in medical sector at a rapid pace is projected to add boost to the overall growth of this market as well. Better flexibility and rising success rates of single-use technology have increased its reliability and popularity worldwide. There is a rising trend towards the adoption of single-use advancements across the medical manufacturing sector. Players of the global single-use technology for biopharmaceuticals market have now made serious efforts to ensure smooth supply and demand of single-use manufacturing, but a few parts of single-use technology require further improvement and are still under study.

Single-use disposable things are most ordinarily used in aseptic processing as a measure for controlling contamination. The applications incorporate gadgets for making aseptic connections, sampling gadgets, blending gadgets, item holding bags, and manifold frameworks that can be disposed of. Innovations in aseptic connection technology have prompted the advancement of single-use connector frameworks to take into account a completely encased and robotized process. These depend on the alpha-beta principle, which permits connectivity in an environment that doesn't need unidirectional airflow cabinets or other hardware for the maintenance of asepsis.

The report on the global single-use technology for biopharmaceuticals market is based on an elaborate overview of the market and factors promoting or demoting its growth. This includes drivers, restraints, challenges, and new growth opportunities. The report also highlights the impact of the novel COVID19 pandemic on this market and how can players benefit from this situation to gain significant revenues during the forecast period. The report further discusses the table of segmentation in details and mentions the names of the leading segment with factors attributing to its growth. Key players and their contribution to the market in the form of new product launches and joint ventures are provided in the report.

Single-use Technology for Biopharmaceuticals Market – Competitive Landscape

The increasing adoption and rising popularity of single-use technology for bio-pharmaceuticals has helped players gain a competitive edge in the overall market competition. The presence of multiple players has helped this market witness an intense competition. Some of them are investing in research and development strategies to gain an upper hand in the overall market competition. Others are engaging in merger and acquisition, joint ventures, and other collaborative strategies to expand brand portfolio and ensure a leading position in the market competition.

Some of the key players of the global single-use technology for biopharmaceuticals market include:

• Merck KgaA
• General Electric Company
• Aber Instruments Ltd
• Infors AG
• Applikon Biotechnology B.V.
• Pall Corporation
• Thermo Fisher Scientific Inc.
• NewAge Industries, Inc.
• W. L. Gore & Associates, Inc.
• Novasep
• BioPure Technology Limited
• Sartorius AG
• Saint-Gobain S.A.
• Dow Corning Corporation
• RENOLIT
• EMD Millipore
• Other players

Single-use Technology for Biopharmaceuticals Market – Innovations

• 3 new single-use technology products namely Pellicon capsule with Ultracel membrane filtration device, Millipak final fill filter, and Mobius Power MIX 2500 mixer were launched by MilliporeSigma in April 2018.

Single-use Technology for Biopharmaceuticals Market – Growth Drivers

The growing awareness about the therapeutic applications of single-use technology for biosimilars and biologics sector will act as the key growth driver for the global single-use technology for biopharmaceuticals market. Besides this, the low manufacturing and maintenance costs of these products have augmented its demand among end-users, thereby attracting more revenues to this market during the forecast period set between 2021 and 2031. On the contrary, stringent regulations imposed on the pricing of various drugs may create big challenges for this market. Nevertheless, increasing number of research and development activities and rising number of collaborative agreements among players to improve product portfolio will further help create new growth opportunities for this market in the coming years.

Single-use Technology for Biopharmaceuticals Market – Geographical Insights

Regionwise, the global single-use technology for biopharmaceutical market is widespread into the regions of North America, Europe, Latin America, and the Middle East and Africa. Each of these regions is further classified on the basis of nations. Among all these, the market is dominated by Europe and North America collectively on account of the presence of major players and the increasing number of new pharmaceutical launches.